IMRIS Inc. and Varian Medical Systems announced that data presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality magnetic resonance (MR) images at each treatment session.
The highest levels of radiation dose in medical imaging are reported in nuclear medicine and pressure is growing for lower dose.
A large number of emergency room visits are for chest pain evaluation, and many hospitals are adopting CT angiography as a primary test to quickly rule-out coronary disease.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
This year the program has set a goal for 100,000 women to make the promise and pass it on to all of the women in their lives. Help reach the goal of 100,000 promises. Make the promise. Then pass it on.
There are numerous ways you can support the American Cancer Society’s mission to help people stay well, get well, find ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
When leaders at Methodist Le Bonheur Healthcare (MLH), a not-for-profit health system based in Memphis, Tenn., saw the opportunity to standardize their suite of diagnostic imaging solutions, they capitalized on it. The seven-hospital system will deploy McKesson’s portfolio of enterprise medical imaging products across its various facilities to help improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
Viztek has announced the upcoming launch of its new PACS/RIS solution, a zero-footprint software platform that can encompass picture archive and communications systems (PACS), specialty viewers and tools including mammography tomosynthesis and positron emission tomography/computed tomography (PET/CT), practice management, electronic health records (EHR), electronic medical records (EMR), billing, radiology scheduling and reporting.
Jan Medical and Brainlab announced a collaboration and Series B funding efforts to complete two clinical trials and the subsequent filing of two product 510(k)s with the U.S. Food and Drug Administration (FDA). Brainlab will also add a member representative to the Jan Medical Board of Directors.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Value-based healthcare is pushing radiologists to deliver the highest quality of care while optimizing time and processes. At RSNA 2013, Nuance will showcase its latest version of PowerScribe 360 — a radiology reporting and communication platform. Powerscribe 360 version 2.0 offers new features like the 99 percent accurate Dragon Medical 12 speech recognition engine, as well as automation tools that increase data accuracy and the speed at which an actionable, structured report is completed.
Parker Laboratories is introducing three, completely redesigned Thermasonic Gel Warmers at RSNA 2013. These include a single bottle gel warmer, a three-bottle gel warmer with preset temperature options and LED indicators, and a three-bottle gel warmer with LCD readout and temperature adjustment in one degree increments, in either Fahrenheit or Celsius.
Limiting the amount of radiation absorbed in the hippocampal portion of the brain during whole-brain radiotherapy (WBRT) for brain metastases preserves memory function in patients for up to six months after treatment, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
In an effort to guide regulation of mobile medical apps, the U.S. Food and Drug Administration (FDA) issued a final guidance document for developers of mobile medical apps.
The American Society for Radiation Oncology (ASTRO) released its list of five radiation oncology-specific treatments that are commonly ordered but may not always be appropriate as part of the national Choosing Wisely campaign, an initiative of the ABIM Foundation. The list identifies five targeted treatment options that ASTRO recommends for detailed patient-physician discussion before being prescribed.
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
The American Society for Radiation Oncology (ASTRO) highlighted the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO’s 55th Annual Meeting, Sept. 22-25, 2013, in Atlanta.
Siemens’ PETNET Solutions has announced a three-year agreement with The US Oncology Network to supply its entire portfolio of Food and Drug Administration (FDA)-approved positron emission tomography (PET) radiopharmaceutical agents at each of PETNET Solutions’ current Good Manufacturing Practices (cGMP)-certified locations throughout the United States.
When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
The ASRT Foundation and RAD-AID International have announced plans to offer a program for radiation therapists to teach in China.
At the 55th American Society for Radiation Oncology (ASTRO) annual meeting, September 22-25 in Atlanta, Royal Philips featured the latest innovations that address efficient and personalized radiation oncology care for patients and their clinicians.
Accuray Inc. announced its momentum in gaining adoption for both the new CyberKnife M6 Series and TomoTherapy H Series Systems at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting taking place at the Georgia World Congress Center in Atlanta. Through presentations from leading radiation oncology practitioners and product demonstrations, attendees can gain further knowledge on the clinical capabilities of the CyberKnife M6 Series and TomoTherapy H Series Systems introduced at last year’s ASTRO meeting.